Mycoplasma gallisepticum and Mycoplasma synoviae in commercial poultry: current control strategies and future challenges.

IF 2.5 2区农林科学 Q1 VETERINARY SCIENCES Avian Pathology Pub Date : 2025-04-01 Epub Date: 2024-11-25 DOI:10.1080/03079457.2024.2419037

Anneke Feberwee, Naola Ferguson-Noel, Salvatore Catania, Marco Bottinelli, Nadeeka Wawagema, Miklos Gyuranecz, Anne V Gautier-Bouchardon, Inna Lysnyansky, Jeanine Wiegel, Franca Möller Palau-Ribes, Ana S Ramirez

{"title":"Mycoplasma gallisepticum and Mycoplasma synoviae in commercial poultry: current control strategies and future challenges.","authors":"Anneke Feberwee, Naola Ferguson-Noel, Salvatore Catania, Marco Bottinelli, Nadeeka Wawagema, Miklos Gyuranecz, Anne V Gautier-Bouchardon, Inna Lysnyansky, Jeanine Wiegel, Franca Möller Palau-Ribes, Ana S Ramirez","doi":"10.1080/03079457.2024.2419037","DOIUrl":null,"url":null,"abstract":"Mycoplasma gallisepticum (Mg) and Mycoplasma synoviae (Ms) are regarded as the most important avian mycoplasma species for today's chicken and turkey farming industry from clinical and economical perspectives. Control strategies for Mg and Ms have become more efficient due to investments in mycoplasma research over the last 70 years. These investments have contributed to the further implementation of serological and molecular testing, the development of vaccines, and the improvement of antimicrobial treatment strategies. However, the increasing spotlight on welfare, the pressure on prudent use of antimicrobials, and the expected global increase in poultry production, are going to have an impact on the future control of avian mycoplasmas in commercial poultry. In this paper a group of avian mycoplasma experts discuss the future challenges in mycoplasma control considering the background of these expected changes and the relevance for future avian mycoplasma research.","PeriodicalId":8788,"journal":{"name":"Avian Pathology","volume":" ","pages":"168-174"},"PeriodicalIF":2.5000,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Avian Pathology","FirstCategoryId":"97","ListUrlMain":"https://doi.org/10.1080/03079457.2024.2419037","RegionNum":2,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/11/25 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"VETERINARY SCIENCES","Score":null,"Total":0}

引用次数: 0

Abstract

Mycoplasma gallisepticum (Mg) and Mycoplasma synoviae (Ms) are regarded as the most important avian mycoplasma species for today's chicken and turkey farming industry from clinical and economical perspectives. Control strategies for Mg and Ms have become more efficient due to investments in mycoplasma research over the last 70 years. These investments have contributed to the further implementation of serological and molecular testing, the development of vaccines, and the improvement of antimicrobial treatment strategies. However, the increasing spotlight on welfare, the pressure on prudent use of antimicrobials, and the expected global increase in poultry production, are going to have an impact on the future control of avian mycoplasmas in commercial poultry. In this paper a group of avian mycoplasma experts discuss the future challenges in mycoplasma control considering the background of these expected changes and the relevance for future avian mycoplasma research.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

家禽中的胆囊支原体和滑膜支原体：当前的控制策略和未来的挑战。

从临床和经济角度来看，五倍子支原体（Mg）和滑液支原体（Ms）被认为是当今鸡和火鸡养殖业中最重要的禽支原体种类。由于过去 70 年来在支原体研究方面的投入，针对 Mg 和 Ms 的控制策略变得更加有效。这些投资促进了血清学和分子检测的进一步实施、疫苗的开发以及抗菌治疗策略的改进。然而，人们对家禽福利的日益关注、谨慎使用抗菌素的压力以及全球家禽产量的预期增长，预计都将对未来商用家禽中禽支原体的控制产生影响。考虑到这些预期变化的背景以及与未来禽支原体研究的相关性，一组禽支原体专家在本文中讨论了支原体控制的未来挑战。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Avian Pathology 农林科学-兽医学

CiteScore

4.50

自引率

10.70%

发文量

审稿时长

1 months

期刊介绍： Avian Pathology is the official journal of the World Veterinary Poultry Association and, since its first publication in 1972, has been a leading international journal for poultry disease scientists. It publishes material relevant to the entire field of infectious and non-infectious diseases of poultry and other birds. Accepted manuscripts will contribute novel data of interest to an international readership and will add significantly to knowledge and understanding of diseases, old or new. Subject areas include pathology, diagnosis, detection and characterisation of pathogens, infections of possible zoonotic importance, epidemiology, innate and immune responses, vaccines, gene sequences, genetics in relation to disease and physiological and biochemical changes in response to disease. First and subsequent reports of well-recognized diseases within a country are not acceptable unless they also include substantial new information about the disease or pathogen. Manuscripts on wild or pet birds should describe disease or pathogens in a significant number of birds, recognizing/suggesting serious potential impact on that species or that the disease or pathogen is of demonstrable relevance to poultry. Manuscripts on food-borne microorganisms acquired during or after processing, and those that catalogue the occurrence or properties of microorganisms, are unlikely to be considered for publication in the absence of data linking them to avian disease.